IR@PKUHSC  > 北京大学临床肿瘤学院  > 胃肠肿瘤中心
学科主题临床医学
A multicenter, phase II study of trastuzumab plus capecitabine and oxaliplatin (XELOX) as first-line chemotherapy for HER2-positive advanced gastric cancer: Update results of efficacy and toxicity.
Gong, Jifang; Liu, Tianshu; Fan, Qingxia; Bai, Li; Bi, Feng; Qin, Shukui; Wang, Jinwan; Xu, Nong; Cheng, Ying; Bai, Yuxian; Liu, Wei; Wang, Liwei; Shen, Lin
刊名JOURNAL OF CLINICAL ONCOLOGY
2014-01-20
suppl.S期:3
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000333682100107
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/56703
专题北京大学临床肿瘤学院_胃肠肿瘤中心
作者单位1.Beijing 301 PLA Hosp, Beijing, Peoples R China
2.Hebei Tumor Hosp, Shijiazhuang, Peoples R China
3.Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China
4.Nanjing Bayi Hosp, PLA Canc Ctr, Nanjing, Jiangsu, Peoples R China
5.Jilin Prov Canc Hosp, Changchun, Peoples R China
6.Heilongjiang Prov Canc Hosp, Harbin, Peoples R China
7.Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
8.Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
9.Sichuan Univ, Dept Med Oncol, West China Hosp, Chengdu 610064, Peoples R China
10.Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China
11.Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China
12.Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China
13.Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Gong, Jifang,Liu, Tianshu,Fan, Qingxia,et al. A multicenter, phase II study of trastuzumab plus capecitabine and oxaliplatin (XELOX) as first-line chemotherapy for HER2-positive advanced gastric cancer: Update results of efficacy and toxicity.[J]. JOURNAL OF CLINICAL ONCOLOGY,2014,suppl.S(3).
APA Gong, Jifang.,Liu, Tianshu.,Fan, Qingxia.,Bai, Li.,Bi, Feng.,...&Shen, Lin.(2014).A multicenter, phase II study of trastuzumab plus capecitabine and oxaliplatin (XELOX) as first-line chemotherapy for HER2-positive advanced gastric cancer: Update results of efficacy and toxicity..JOURNAL OF CLINICAL ONCOLOGY,suppl.S(3).
MLA Gong, Jifang,et al."A multicenter, phase II study of trastuzumab plus capecitabine and oxaliplatin (XELOX) as first-line chemotherapy for HER2-positive advanced gastric cancer: Update results of efficacy and toxicity.".JOURNAL OF CLINICAL ONCOLOGY suppl.S.3(2014).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Gong, Jifang]的文章
[Liu, Tianshu]的文章
[Fan, Qingxia]的文章
百度学术
百度学术中相似的文章
[Gong, Jifang]的文章
[Liu, Tianshu]的文章
[Fan, Qingxia]的文章
必应学术
必应学术中相似的文章
[Gong, Jifang]的文章
[Liu, Tianshu]的文章
[Fan, Qingxia]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。